Inter-American Dev - Issue of Debt
RNS Number : 3934R
Inter-American Development Bank
16 July 2025
PRICING SUPPLEMENT
Inter-American Development Bank
Global Debt Program
Series No.: 1000
U.S.$3,000,000,000 4.375 percent Notes due July 16, 2035 (the "Notes")
Issue Price: 99.113 percent
Application has been made for the Notes to be admitted to the
Official List of the Financial Conduct Authority and
to trading on the London Stock Exchange plc's
UK Regulated Market
Deutsche Bank
Nomura
TD Securities
Wells Fargo Securities
Barclays
BMO Capital Markets
BNP Paribas
BofA Securities
Citigroup
HSBC
J.P. Morgan
Morgan Stanley
National Bank of Canada Financial Markets
Scotiabank
The date of this Pricing Supplement is July 14, 2025.
Terms used herein shall be deemed to be defined as such for the purposes of the Terms and Conditions (the "Conditions") set forth in the Prospectus dated July 28, 2020 (the "Prospectus") (which for the avoidance of doubt does not constitute a prospectus for the purposes of Part VI of the United Kingdom ("UK") Financial Services and Markets Act 2000 or a base prospectus for the purposes of Regulation (EU) 2017/1129 (as amended, the "Prospectus Regulation") or the Prospectus Regulation as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA")). This Pricing Supplement must be read in conjunction with the Prospectus. This document is issued to give details of an issue by the Inter-American Development Bank (the "Bank") under its Global Debt Program and to provide information supplemental to the Prospectus. Complete information in respect of the Bank and this offer of the Notes is only available on the basis of the combination of this Pricing Supplement and the Prospectus.
MiFID II and UK MiFIR product governance / Retail investors, professional investors and ECPs target market - See "General Information-Additional Information Regarding the Notes-Matters relating to MiFID II and UK MiFIR" below.
Terms and Conditions
The following items under this heading "Terms and Conditions" are the particular terms which relate to the issue the subject of this Pricing Supplement. Together with the applicable Conditions (as defined above), which are expressly incorporated hereto, these are the only terms that form part of the form of Notes for such issue.
| 1. | Series No.: | 1000 |
| 2. | Aggregate Principal Amount: | U.S.$3,000,000,000 |
| 3. | Issue Price: | U.S.$2,973,390,000 which is 99.113 percent of the Aggregate Principal Amount |
| 4. | Issue Date: | July 16, 2025 |
| 5. | Form of Notes (Condition 1(a)): | Book-entry only (not exchangeable for Definitive Fed Registered Notes, Conditions 1(a) and 2(b) notwithstanding) |
| 6. | Authorized Denomination(s) (Condition 1(b)): | U.S.$1,000 and integral multiples thereof |
| 7. | Specified Currency (Condition 1(d)): | United States Dollars (U.S.$) being the lawful currency of the United States of America |
| 8. | Specified Principal Payment Currency (Conditions 1(d) and 7(h)): | U.S.$ |
| 9. | Specified Interest Payment Currency (Conditions 1(d) and 7(h)): | U.S.$ |
| 10. | Maturity Date (Condition 6(a); Fixed Interest Rate and Zero Coupon): | July 16, 2035 |
| 11. | Interest Basis (Condition 5): | Fixed Interest Rate (Condition 5(I)) |
| 12. | Interest Commencement Date (Condition 5(III)): | Issue Date (July 16, 2025) |
| 13. | Fixed Interest Rate (Condition 5(I)): (a) Interest Rate: | 4.375 percent per annum |
| (b) Fixed Rate Interest Payment Date(s): | Semi-annually in arrear on January 16 and July 16 in each year, commencing on January 16, 2026, up to and including the Maturity Date. Each Fixed Rate Interest Payment Date is subject to the Business Day Convention, but with no adjustment to the amount of interest otherwise calculated. | |
| (c) Business Day Convention: | Following Business Day Convention | |
| (d) Fixed Rate Day Count Fraction(s): | 30/360 | |
| 14. | Relevant Financial Center: | New York |
| 15. | Relevant Business Day: | New York |
| 16. | Issuer's Optional Redemption (Condition 6(e)): | No |
| 17. | Redemption at the Option of the Noteholders (Condition 6(f)): | No |
| 18. | Governing Law: | New York |
Other Relevant Terms | ||
| 1. | Listing: | Application has been made for the Notes to be admitted to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange plc's UK Regulated Market |
| 2. | Details of Clearance System Approved by the Bank and the Global Agent and Clearance and Settlement Procedures: | Federal Reserve Bank of New York; Euroclear Bank SA/NV; Clearstream Banking S.A. |
| 3. | Syndicated: | Yes |
| 4. | If Syndicated: | |
| (a) Liability: | Several | |
| (b) Lead Managers: | Deutsche Bank AG, London Branch Nomura International plc The Toronto-Dominion Bank Wells Fargo Securities, LLC | |
| 5. | Commissions and Concessions: | 0.175 percent of the Aggregate Principal Amount |
| 6. | Estimated Total Expenses: | The Lead Managers have agreed to pay for all material expenses related to the issuance of the Notes, except the Issuer will pay for the London Stock Exchange listing fees, if applicable. |
| 7. | Codes: | |
| (a) Common Code: | 312354209 | |
| (b) ISIN: | US4581X0EW42 | |
| (c) CUSIP: | 4581X0EW4 | |
| 8. | Identity of Managers: | Deutsche Bank AG, London Branch Nomura International plc The Toronto-Dominion Bank Wells Fargo Securities, LLC Barclays Bank PLC BMO Capital Markets Corp. BNP PARIBAS Citigroup Global Markets Limited HSBC Bank plc J.P. Morgan Securities plc Merrill Lynch International Morgan Stanley & Co. International plc National Bank of Canada Financial Inc. The Bank of Nova Scotia, London Branch |
| 9. | Selling Restrictions: (a) United States: | Under the provisions of Section 11(a) of the Inter-American Development Bank Act, the Notes are exempted securities within the meaning of Section 3(a)(2) of the U.S. Securities Act of 1933, as amended, and Section 3(a)(12) of the U.S. Securities Exchange Act of 1934, as amended. |
| (b) United Kingdom: | Each of the Managers represents and agrees that (a) it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000 (the "FSMA")) received by it in connection with the issue or sale of the Notes in circumstances in which Section 21(1) of the FSMA does not apply to the Bank, and (b) it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to such Notes in, from or otherwise | |
| involving the UK. | ||
| (c) Singapore: | Each of the Managers represents, warrants and agrees, that it has not offered or sold any Notes or caused the Notes to be made the subject of an invitation for subscription or purchase and will not offer or sell any Notes or cause the Notes to be made the subject of an invitation for subscription or purchase, and has not circulated or distributed, nor will it circulate or distribute the Prospectus, this Pricing Supplement or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the Notes, whether directly or indirectly, to any person in Singapore other than: (i) to an institutional investor (as defined in Section 4A of the SFA) pursuant to Section 274 of the SFA or (ii) to an accredited investor (as defined in Section 4A of the SFA) pursuant to and in accordance with the conditions specified in Section 275 of the SFA and (where applicable) Regulation 3 of the Securities and Futures (Classes of Investors) Regulations 2018 of Singapore. Investors should note that there may be restrictions on the secondary sale of the Notes under Section 276 of the SFA. Any reference to the SFA is a reference to the Securities and Futures Act 2001 of Singapore and a reference to any term that is defined in the SFA or any provision in the SFA is a reference to that term or provision as amended or modified from time to time including by such of its subsidiary legislation as may be applicable at the relevant time. In the case of the Notes being offered into Singapore in a primary or subsequent distribution, and solely for the purposes of its obligations pursuant to Section 309B of the SFA, the Issuer has determined, and hereby notifies all relevant persons (as defined in Section 309A of the SFA) that the Notes are | |
| (d) General: | "prescribed capital markets products" (as defined in the Securities and Futures (Capital Markets Products) Regulations 2018 of Singapore) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products). No action has been or will be taken by the Issuer that would permit a public offering of the Notes, or possession or distribution of any offering material relating to the Notes in any jurisdiction where action for that purpose is required. Accordingly, each of the Managers agrees that it will observe all applicable provisions of law in each jurisdiction in or from which it may offer or sell Notes or distribute any offering material. |